Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / October / Precision in Early Glaucoma VF Defects
Glaucoma Insights

Precision in Early Glaucoma VF Defects

Quantitative classification brings objectivity to early glaucoma visual field analysis

By The Ophthalmologist 10/28/2025 3 min read

Share

Credit: AdobeStock.com
Visual field (VF) assessment remains the cornerstone of glaucoma diagnosis and monitoring. Yet, despite the availability of established qualitative systems, such as those from the Ocular Hypertension Treatment Study (OHTS), subjective interpretation continues to introduce interobserver variability. In a new Ophthalmology Glaucoma study, however, researchers from the University of New South Wales, Australia, have proposed an objective quantitative classification method for VF defects in early glaucoma, aiming to enhance diagnostic precision and reproducibility.

The study involved 1330 eyes from 733 subjects with healthy, suspect, or early glaucoma enrolled in the Frontloading Fields Study at the University of New South Wales. Each eye underwent two consecutive 24-2 SITA-Faster tests, enabling the authors to compare “initial” and “repeatable” VF defects within the same session.

The OHTS classification system – which originally relied on qualitative grading by trained readers – was translated into a quantitative, algorithm-driven model. Using numerical thresholds for probability values across the pattern deviation grid, the authors defined 14 distinct defect patterns, grouped into nerve fiber bundle (bundle) and non-bundle categories.

Among repeatable VF defects, the inferior nasal step emerged as most prevalent (22.6%), followed by the inferior enlarged blind spot (19.1%), superior nasal step (12.6%), and superior enlarged blind spot (11.6%). The frequency of defects was lower when repeatability was required, reflecting the filtering out of spurious findings. As mean deviation (MD) worsened, nasal step defects decreased in frequency while arcuate defects increased, suggesting a progression pattern from focal to more extensive nerve fiber loss.

The study authors argue that objective, rule-based classification offers multiple benefits: improved consistency between clinicians, standardized definitions for research, and educational utility in training environments. In clinical terms, such standardization could enhance early glaucoma detection and support consistent application of NICE referral criteria, which hinge on the identification of VF defects “consistent with glaucoma.”

This large-scale study demonstrates that a quantitative translation of the OHTS system can reproducibly identify common early glaucomatous defect patterns. The most frequent early changes — nasal step and enlarged blind spot — align with known anatomical pathways of retinal nerve fiber damage. By moving VF analysis from subjective judgment to objective computation, this approach may represent a significant step forward in precision glaucoma care.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: